Trends in incidence, initial treatment and survival of myelodysplastic syndromes: A population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010
- 2 January 2014
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 50 (5), 1004-1012
- https://doi.org/10.1016/j.ejca.2013.12.002
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Revised International Prognostic Scoring System for Myelodysplastic SyndromesBlood, 2012
- Incidence and prevalence of myelodysplastic syndromes: Data from the Düsseldorf MDS-registryLeukemia Research, 2011
- Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research NetworkBritish Journal of Cancer, 2011
- Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE projectBlood, 2010
- Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring SystemCancer, 2008
- Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programsBlood, 2008
- Myelodysplastic syndromesBlood, 2008
- A prognostic score for patients with lower risk myelodysplastic syndromeLeukemia, 2007
- Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic SyndromesJournal of Clinical Oncology, 2007
- Myelodysplastic syndromesCancer, 2007